influenza A(H7N9) - Providence Business News

Home Tags Influenza A(H7N9)

EPIVAX PRESIDENT AND CEO Dr. Anne S. De Groot. EpiVax has joined an National Institutes of Health partnership to research a vaccine for the influenza A (H7N9) virus. / PBN FILE PHOTO/MICHAEL SALERNO

EpiVax leads NIH’s $5.8M bird-flu vaccine project

Health Services 09/18/2017

PROVIDENCE - Immunolgy engineering biotech firm EpiVax Inc. is leading a National Institutes of Health-funded $5.8 million collaboration developing a protective vaccine against avian influenza...

- Featured Event -

Latest News

Citizens partners with MIT Solve on $100,000 Workforce Innovation Prize

03/24/2025

Five Questions With: Eddy E. Grijalva

03/24/2025

Centreville Bank awards $100K grant to support new Central Falls community...

03/24/2025

Bristol Country Savings Bank names Clayton VP and senior marketing officer

03/24/2025

‘March Madness’ a slam dunk for local restaurants, businesses over the...

03/24/2025

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.